A-431 In Vitro Nitric Oxide Synthases Assay (Oxidative Stress)
CAT#: ITS-1122-YF1332
Target Cell Organism: Human
Target Cell Alternative Name: A431
Target Cell Name: A-431
Assay Type: Oxidative Stress Assays
Assay Overview
This assay is to provide A-431-based In Vitro Nitric Oxide Synthases Assay (Oxidative Stress) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
A-431
Target Cell Organism
Human
Target Cell Background
A-431 is a cell line exhibiting epithelial morphology that was isolated from the epidermis of an 85-year-old female patient with epidermoid carcinoma. This cell line is one of a series of cell lines established from solid tumors by D.J. Giard, et al. and can be used in cancer, toxicology, and immuno-oncology research.
Target Cell Alternative Name
A431
Related Diseases
Epidermoid Carcinoma
Research Area
Oncology
Assay Name
In Vitro Nitric Oxide Synthases Assay (Oxidative Stress)
Short Description
A-431-cell based In Vitro Nitric Oxide Synthases Assay (Oxidative Stress)
Assay Description
Wide ranges of enzyme assays are also available to detect oxidative stress at the cellular level. Enzymes such as NO synthases and xanthine oxidase are known to generate ROS. Enzymes namely superoxide dismutase, catalase and thioredoxin reductase can prevent cells from oxidative damage. GST is another enzyme involved in oxidative stress that catalyzes the reduction of oxidized GSH to GSH.
Assay Type
Oxidative Stress Assays
Assay Type Details
Disturbance between the production of reactive oxygen species (ROS), free radicals and antioxidant mechanisms is defined as the oxidative stress, or more precisely, it is an imbalance between the oxidant and antioxidant state in cells. This imbalance can cause harmful effects to cells and biomolecules, which ultimately causes adverse effects in the whole organism. Oxidative imbalance can target important proteinsand lipids in cells, which can increase the risk of developing a cancer. On the other hand, increased ROS production in cancer cells by certain cancer drugs can also arrest cancer cell cycle and cause senescence and apoptosis through oxidative stress.